[Transbronchial lung cryobiopsy in interstitial lung diseases].

Les cryobiopsies pulmonaires transbronchiques dans les pneumopathies infiltrantes diffuses.
Anatomopathologie clinique Bronchoscopie Bronchoscopy Clinical pathology Fibrose pulmonaire idiopathique Histologie Histology Idiopathic pulmonary fibrosis Interstitial lung diseases Pneumopathie interstitielle

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 15 11 2022
accepted: 13 04 2023
medline: 14 6 2023
pubmed: 13 6 2023
entrez: 12 6 2023
Statut: ppublish

Résumé

In some cases of interstitial lung disease (ILD), clinical and biological findings associated with CT scan pattern during multidisciplinary discussion (MDD) fail to yield a confident diagnosis. In these cases, histology may be necessary. Transbronchial lung cryobiopsy (TBLC) is a bronchoscopic procedure that has been developed in recent years and currently contributes to diagnostic work-up in patients with ILD. TBLC provides tissue samples for histological analysis with an acceptable risk of complications, consisting mainly in pneumothorax or bleeding. In addition to higher diagnostic yield than conventional forceps biopsies, the procedure shows a better safety profile than surgical biopsies. The indication to perform TBLC is decided during a 1st MDD and during a 2nd MDD, results can provide a diagnostic yield approximating 80%. TBLC appears to be an attractive, minimally invasive technique to be proposed as a first-line procedure in selected patients in experienced centers, while surgical lung biopsy may be considered as a second-line solution.

Identifiants

pubmed: 37308261
pii: S0761-8425(23)00141-9
doi: 10.1016/j.rmr.2023.04.003
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

469-478

Informations de copyright

Copyright © 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

C Menigoz (C)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France. Electronic address: charlotte.menigoz@chu-nantes.fr.

S Dirou (S)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France.

C Sagan (C)

Nantes Université, CHU Nantes, service d'anatomopathologie, Nantes, France.

F Corne (F)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France; Clinique Jules Verne, consultation de pneumologie, Nantes, France.

A Moui (A)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France.

C Defrance (C)

Nantes Université, CHU Nantes, service d'imagerie médicale, Nantes, France.

R Liberge (R)

Nantes Université, CHU Nantes, service d'imagerie médicale, Nantes, France.

O Morla (O)

Nantes Université, CHU Nantes, service d'imagerie médicale, Nantes, France.

V Patarin (V)

Nantes Université, CHU Nantes, service d'imagerie médicale, Nantes, France.

A Nicolas (A)

Nantes Université, CHU Nantes, service d'imagerie médicale, Nantes, France.

C Kandel-Aznar (C)

Nantes Université, CHU Nantes, service d'anatomopathologie, Nantes, France.

P Lacoste (P)

Nantes Université, CHU Nantes, service de chirurgie thoracique et cardiovasculaire, l'institut du thorax, Nantes, France.

J P Clarke (JP)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France; Clinique ELSAN Santé Atlantique, consultation de pneumologie, Saint-Herblain, France.

A Cavailles (A)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France.

L Cellerin (L)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France.

F-X Blanc (FX)

Nantes Université, CHU Nantes, service de pneumologie, l'institut du thorax, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH